This bill, titled the Future of Artificial Intelligence Innovation Act of 2026, creates a new Center for Artificial Intelligence Standards and Innovation within the National Institute of Standards and Technology to develop voluntary testing standards, evaluation tools, and best practices for AI systems. The bill establishes testbed programs that allow companies of all sizes to access federal computing resources and facilities for testing AI technologies, while also creating international coalitions with like-minded countries to align on AI standards and security measures. It authorizes federal agencies to award prizes for solving specific AI challenges and requires a report identifying regulatory barriers that may hinder AI innovation. The legislation also expands hiring authority for technical experts and adds requirements for auditing temporary workers involved in AI research.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
Resident Education Deferred Interest Act or the REDI Act This bill allows borrowers in medical or dental internships or residency programs to defer student loan payments until the completion of their programs.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
This bill requires health insurance plans to cover prostate cancer screenings without copays or deductibles for men aged 40+ who are at high risk of prostate cancer. It specifically applies to African-American men and men with a family history of prostate cancer (defined as having a first-degree relative diagnosed with the disease or genetic risk factors). The law amends existing coverage requirements to include these screenings as a preventive service, aiming to address disparities in late-stage diagnosis and improve early detection rates. The policy change takes effect for plan years beginning January 1, 2025.
Bill to Outlaw Wounding of Official Working Animals Act or the BOWOW Act This bill establishes that a non-U.S. national ( alien under federal law) convicted of, or who admits to having committed, an offense related to harming animals used in law enforcement is inadmissible and deportable.
HR 556, the Protecting Access for Hunters and Anglers Act, prevents federal agencies from banning lead ammunition or tackle on public lands and waters managed for hunting or fishing. It directly affects hunters and anglers using federal lands (like national wildlife refuges, public forests, and BLM lands) by blocking nationwide restrictions on lead products. The bill allows limited exceptions only for specific locations where wildlife decline is directly linked to lead use, and the restriction must align with state law or get approval from the state wildlife agency. This changes how federal land managers can regulate lead, requiring state coordination for any local restrictions.
This bill prohibits AI chatbots from misleading users into believing they are licensed professionals in fields like law, healthcare, finance, accounting, or insurance. It requires companies deploying AI chatbots to avoid generating content that falsely implies the AI has professional credentials or human verification from a licensed practitioner. The Federal Trade Commission would enforce these rules as unfair or deceptive practices, while state attorneys general could also sue for violations and seek damages. Individuals harmed by such violations could file lawsuits to recover actual losses or up to $5,000 per violation, with higher penalties for willful misconduct.
The Energy Bills Relief Act aims to lower household energy costs and accelerate the development of low-cost, clean energy by modifying federal tax credits, expanding weatherization programs, and streamlining permitting processes. Key provisions include restoring tax incentives for renewable energy projects, increasing funding for low-income heating assistance, and requiring federal agencies to treat wind, solar, and storage projects with the same procedural fairness as oil and gas projects. The bill also establishes new incentives for upgrading the electricity grid, such as tax credits for transmission lines and grants for wildfire prevention measures, while creating mechanisms to ensure utilities serve public interests and protect consumers from price volatility.
This bill establishes a collaborative research initiative to study health conditions affecting descendants of veterans exposed to toxic substances during military service. Within 180 days, it requires an interagency task force (including the Agency for Toxic Substances and Disease Registry) to research diagnosis and treatment options for these health conditions. The task force must maintain a public website sharing research findings and evidence reviews on links between specific toxic exposures and health outcomes. It also mandates annual reports on research progress and strategic plan implementation for five years. The bill directly affects descendants of veterans with toxic exposure histories, focusing on evidence-based research rather than immediate healthcare benefits.
